Table 1 Patient data
Number of patients | 55 |
|---|---|
Age (years) | |
Mean (SD) | 68.3 (6.9) |
Range | 48–83 |
Gleason score | |
3 + 3 | 9 |
3 + 4 | 16 |
4 + 3 | 12 |
4 + 4 | 6 |
5 + 3 | 1 |
4 + 5 | 9 |
5 + 4 | 1 |
Unknown | 1 |
PSA at diagnosis (ng/mL) | |
Mean (SD) | 11.2 (12.5) |
Range | 4.0–88.0 |
Post-treatment PSA nadir (ng/mL) | |
Mean (SD) | 0.5 (1.1) |
Range | 0–5.1 |
Post-treatment PSA (ng/mL) | |
Mean (SD) | 7.9 (12.9) |
Range | 0.2–84.0 |
PSA doubling time (months) | |
Mean (SD) | 7.1 (6.6) |
Post-treatment PSA grouping (n) | |
0–1 ng/mL | 8 (14.5%) |
1–2 ng/mL | 10 (18.2%) |
> 2 ng/mL | 37 (67.3%) |
Treatment (n) | |
Prostatectomy | 16 (29.1%) |
Radiation | 18 (32.7%) |
Prostatectomy and radiation | 21 (38.2%) |